| dc.contributor.author | Wensvoort, Nick Robert Pieter | |
| dc.date.accessioned | 2023-09-07T22:00:24Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Wensvoort, Nick Robert Pieter. The added value of value-of-information analysis for pharmaceutical companies: A case study on Ondexxya® for FXa-inhibitors related major uncontrolled bleedings in the Netherlands. Master thesis, University of Oslo, 2023 | |
| dc.identifier.uri | http://hdl.handle.net/10852/104519 | |
| dc.description.abstract | | eng |
| dc.language.iso | eng | |
| dc.subject | | |
| dc.title | The added value of value-of-information analysis for pharmaceutical companies: A case study on Ondexxya® for FXa-inhibitors related major uncontrolled bleedings in the Netherlands | eng |
| dc.type | Master thesis | |
| dc.date.updated | 2023-09-07T22:00:24Z | |
| dc.creator.author | Wensvoort, Nick Robert Pieter | |
| dc.date.embargoenddate | 3023-06-01 | |
| dc.rights.terms | KLAUSULERING: Dokumentet er klausulert grunnet lovpålagt taushetsplikt. Tilgangskode/Access code C | |
| dc.type.document | Masteroppgave | |
| dc.rights.accessrights | closedaccess | |